The transition from accelerated to traditional approval is backed by robust 24-month eGFR data from the phase 3 APPLAUSE-IgAN trial.

Most ION events occurred in men, patients 50 years or older, with minimal risk seen in women, patients younger than 50 years ...

Targeting effective control of rheumatoid arthritis disease activity is crucial component of treatment strategy.

Supported by phase 3 SYMPHONY and ENCORE trial data, AXS-12 significantly reduced weekly cataplexy attacks and improved daytime sleepiness and cognition.

Credit: Merck. Supported by the phase 3 CORALreef program, Merck’s once-daily oral macrocyclic peptide offers a non-injectable PCSK9-targeting pathway to significantly clear LDL-C in adults. Lipfendra ...

Clinicians should maintain a high index of suspicion for Cyclospora in patients presenting with prolonged or relapsing watery diarrhea this summer.

At 12 months, adults with insulin-treated diabetes had significant improvements in HbA1c and hospitalizations.

FDA clears subcutaneous Sarclisa Escena for multiple myeloma, showing comparable overall response rates to IV delivery.

Higher vitamin A is associated with better lung function in children and adults, while vitamin D levels are associated with lower epigenetic aging in asthma in ...

Most US adults using social media report some health-related engagement with social media, according to a research letter published online June 30 in the Journal of the American Medical Association.

Treatments for fibrodysplasia ossificans progressiva, gastroenteropancreatic neuroendocrine tumors, HIV, influenza, and multiple myeloma are under review.

FDA Drug Approvals and Regulatory Updates Drug Pharmacologic class Indication More information Cardiovascular Disease Tryngolza (olezarsen) Apolipoprotein ...